Foresite Capital | Investing In Healthcare and Life Sciences

OUR MISSION

Catalyzing the

Transformation

of Healthcare

Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles. We use a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.

how we transform

Strategy

We are focused on breakthrough opportunities at the intersection of tech and biotech, with a deeply technical investment team. Our thesis-driven investment process systematically identifies key undercurrents driving change.

Learn More

THE CATALYSTS

Portfolio

We fund the visionaries who are transforming healthcare.

Learn More

MEET THE TEAM

People

The Foresite Capital team has the experience, insights and connections needed to find and support visionaries who are changing the world.

Learn More

“The Foresite Capital team has been fantastic to work with, particularly as we've transitioned from a startup to a growth stage company. We’ve collaborated closely on a number of different points: financing, recruiting and strategy for example. It’s a true partnership.”

Nima Farzan, CEO
Kinnate Biopharma
(See Disclosures)

"Foresite Capital has been a visionary partner."

Serge Saxonov, CEO & Co-Founder
10x Genomics
(See Disclosures)

“Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance.”

Tim Clackson
Theseus Pharmaceuticals
(See Disclosures)

"The Foresite team contributed meaningful scientific and strategic insights that supported our path from concept to acquisition in just over two years. Their partnership allowed our small team to move more quickly and decisively than we could have alone."

Chris LeMasters
XinThera
(See Disclosures)

"The Foresite Capital team has been great collaborators as we work to push the bounds of what is possible when disparate healthcare data can be combined and accessed in a privacy-compliant manner."

Andrew Kress
Health Verity
(See Disclosures)

Foresite Capital has championed the growth of Eikon Therapeutics from a simple whiteboard exercise through its transformation into a powerful, clinical-stage biopharmaceutical company. They have been an ideal strategic partner throughout our extraordinary journey.

Roger M. Perlmutter
Eikon Therapeutics
(See Disclosures)

JOIN OUR NETWORK

Careers

Learn More

Foresite News

News & Press Releases Foresite Blog

Catalyzing the

Transformation

of Healthcare

Strategy

Portfolio

People

“The Foresite Capital team has been fantastic to work with, particularly as we've transitioned from a startup to a growth stage company. We’ve collaborated closely on a number of different points: financing, recruiting and strategy for example. It’s a true partnership.”

"Foresite Capital has been a visionary partner."

“Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance.”

"The Foresite team contributed meaningful scientific and strategic insights that supported our path from concept to acquisition in just over two years. Their partnership allowed our small team to move more quickly and decisively than we could have alone."

"The Foresite Capital team has been great collaborators as we work to push the bounds of what is possible when disparate healthcare data can be combined and accessed in a privacy-compliant manner."

Foresite Capital has championed the growth of Eikon Therapeutics from a simple whiteboard exercise through its transformation into a powerful, clinical-stage biopharmaceutical company. They have been an ideal strategic partner throughout our extraordinary journey.

Careers

Foresite News

Foresite Blog

Thyme Care – Transforming the Oncology Patient Experience Head-On

CG Oncology

CG Oncology reels in $105M crossover for potential late 2024 bladder cancer drug filing

TechCrunch

Foresite Capital raises $969 million fund to invest in healthcare startups across all stages of growth

Element Biosciences

Element Biosciences unveils Aviti benchtop sequencing system

Business Insider

RISING STARS: Meet the 16 up-and-coming investors changing the face of healthcare in the US

Medium

Foresite Labs: Supporting the Next Generation of Healthcare Entrepreneurs